These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 281191)

  • 21. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
    Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [About the acute promyelocytic leukaemia (author's transl)].
    Bernard J; Flandrin G
    Nouv Rev Fr Hematol; 1973; 13(6):755-60. PubMed ID: 4280041
    [No Abstract]   [Full Text] [Related]  

  • 23. Trial of daunomycin in acute promyelocytic leukemia of childhood: a Southwest Oncology Group Study.
    van Eys J; Steuber P; Haggard ME; Sabio H; Duncan M
    Am J Pediatr Hematol Oncol; 1981; 3(3):301-3. PubMed ID: 7025685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Remission induction with daunomycin, vincristine, and prednisone in adult acute lymphocytic leukemia.
    Einhorn LH; Bond WH
    Oncology; 1977; 34(1):25-8. PubMed ID: 266674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute promyelocytic leukemia is a distinct subset of acute myelocytic leukemia with unique clinicopathologic characteristics including longer duration of relapse free survival: experience in 13 cases.
    Lee KH; Kim DH; Lee JS; Suh CW; Kim SW; Kim SB; Lee JH; Doh BS; Chi HS; Lee MS
    J Korean Med Sci; 1994 Dec; 9(6):437-43. PubMed ID: 7786438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. THP-ADM in the treatment of acute promyelocytic leukemia.
    Uzuka Y; Saito Y
    Tohoku J Exp Med; 1985 May; 146(1):1-8. PubMed ID: 3861002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute promyelocytic leukemia: results of therapy and analysis of 13 cases.
    Ruggero D; Baccarani M; Guarini A; Gugliotta L; Gobbi M; Ricci P; Zaccaria A; Lauria F; Tomasini I; Fiacchini M; Santucci MA; Tura S
    Acta Haematol; 1977; 58(2):108-19. PubMed ID: 409019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute promyelocytic leukemia in children.
    Chan KW; Steinherz PG; Miller DR
    Med Pediatr Oncol; 1981; 9(1):5-15. PubMed ID: 6936607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Daunorubicin, cytosine arabinoside, 6-mercaptopurine riboside, and prednisolone (DCMP) combination chemotherapy for acute myelogenous leukemia in adults.
    Ohno R; Hirano M; Imai K; Koie K; Kamiya T; Nishiwaki H; Ishiguro J; Uetani T; Sako F; Imamura K
    Cancer; 1975 Dec; 36(6):1945-9. PubMed ID: 1060503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of remission in acute promyelocytic leukemia with mitoxantrone.
    Mittelman A; Rieber E; Friedland ML; Arlin ZA
    Cancer Chemother Pharmacol; 1985; 14(1):81-2. PubMed ID: 3855290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Results of therapy in adult acute lymphocytic leukemia.
    Einhorn LH; Meyer S; Bond WH; Rohn RJ
    Oncology; 1975; 32(5-6):214-20. PubMed ID: 1064827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of thioguanine on a combination of daunorubicine, cytarabine and prednisone in the treatment of acute leukaemia in adults. The Finnish Leukaemia Group.
    Scand J Haematol; 1979 Aug; 23(2):124-8. PubMed ID: 291122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Acute promyelocytic leukemia. Review of the literature].
    Virgolini L
    Minerva Med; 1984 Jul; 75(30-31):1797-802. PubMed ID: 6090991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interhospital differences in the treatment of acute leukaemia in adults. The Finnish Leukaemia Group.
    Scand J Haematol; 1979 Aug; 23(2):119-23. PubMed ID: 386480
    [No Abstract]   [Full Text] [Related]  

  • 35. [Difficulties of remission induction treatment of acute myeloblastic leukemia].
    Fière D; Bryon PA; Martin C; Revol L
    Sem Hop; 1974 May; 50(25):1691-4. PubMed ID: 4369538
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of disseminated intravascular coagulation in acute promyelocytic leukemia with low molecular weight heparinoid Org 10172.
    Nieuwenhuis HK; Sixma JJ
    Cancer; 1986 Aug; 58(3):761-4. PubMed ID: 2425925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravascular coagulation and fibrinolysis syndrome (ICF) in acute non-promyelocytic leukemia.
    Kotschy M; Kotlarek-Haus S; Podolak-Dawidziak M; Nowicka J; Dzik T
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1980; 107(1):65-73. PubMed ID: 6157626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Heparin as treatment for hypercoagulability syndrome in a case of acute promyelocytic leukemia].
    Pizzuto J; Gonzalez Llaven J; Uribe Cortes JA
    Sangre (Barc); 1969; 14(3):363-70. PubMed ID: 5288844
    [No Abstract]   [Full Text] [Related]  

  • 39. Induction and maintenance of remission in acute leukemia. Effectiveness of combination therapy in 227 patients.
    Pavlovsky S; Peñalver J; Eppinger-Helft M; Muriel FS; Bergna L; Suárez A; Vilaseca G; Pavlovsky AA; Pavlovsky A
    Cancer; 1973 Feb; 31(2):273-9. PubMed ID: 4510669
    [No Abstract]   [Full Text] [Related]  

  • 40. [Combination chemotherapy of acute myeloblastic leukemias (author's transl)].
    Bauters F; Mouton J; Carrez J; Goudemand M
    Nouv Rev Fr Hematol; 1974; 14(5):653-62. PubMed ID: 4281478
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.